PharmaResources (Shanghai) Co., Ltd. Stock: price and insider trades · China
泓博医药
PharmaResources (Shanghai) Co., Ltd.: what insiders have been doing
PharmaResources (Shanghai) Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). In the past year (5 November 2025 to 5 November 2026), 1 filing came from 1 insider.
No insider bought on the market over the period, while 1 insider filed 1 sale totalling €21.4M. One trade stands out by size: a sale of €21.4M from 泓博智源(香港)医药技术有限公司, disclosed on 30 December 2025.
Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Compared with its exchange (521 companies, median 2 filings), a count of 1 filing is below the norm. Looking back to 2024, when coverage begins, insiders filed no purchases and 2 sales.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 6,979,330 shares100.0% of flowA股XSHESZSE:273000000077298800
- 14,000 shares100.0% of flowA股XSHESZSE:173000007455257820
2 of 2 declarations
About PharmaResources (Shanghai) Co., Ltd.
泓博医药 is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
